Paloma Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,273
| Closed | -$1.36M | – | 386 |
|
|
2024
Q3 | $1.36M | Sell |
16,273
-5,134
| -24% | -$405K | 0.04% | 350 |
|
|
2024
Q2 | $1.65M | Buy |
+21,407
| New | +$1.57M | 0.05% | 391 |
|
|
2023
Q2 | – | Sell |
-18,392
| Closed | -$920K | – | 752 |
|
|
2023
Q1 | $920K | Buy |
+18,392
| New | +$867K | 0.03% | 386 |
|
|
2022
Q3 | – | Sell |
-9,204
| Closed | -$343K | – | 1033 |
|
|
2022
Q2 | $343K | Sell |
9,204
-28,983
| -76% | -$1.18M | 0.01% | 728 |
|
|
2022
Q1 | $1.69M | Buy |
+38,187
| New | +$1.65M | 0.05% | 284 |
|
|
2021
Q3 | – | Sell |
-26,291
| Closed | -$1.12M | – | 1140 |
|
|
2021
Q2 | $1.12M | Sell |
26,291
-3,132
| -11% | -$132K | 0.02% | 587 |
|
|
2021
Q1 | $1.14M | Sell |
29,423
-145,584
| -83% | -$5.51M | 0.02% | 634 |
|
|
2020
Q4 | $6.29M | Buy |
175,007
+104,062
| +147% | +$3.75M | 0.17% | 128 |
|
|
2020
Q3 | $2.71M | Sell |
70,945
-52,694
| -43% | -$2.03M | 0.07% | 293 |
|
|
2020
Q2 | $4.34M | Buy |
123,639
+118,293
| +2,213% | +$4.26M | 0.08% | 343 |
|
|
2020
Q1 | $174K | Sell |
5,346
-35,455
| -87% | -$1.39M | 0.01% | 936 |
|
|
2019
Q4 | $1.84M | Sell |
40,801
-55,719
| -58% | -$2.33M | 0.03% | 628 |
|
|
2019
Q3 | $3.93M | Buy |
+96,520
| New | +$4.09M | 0.08% | 200 |
|
|
2019
Q2 | – | Sell |
-49,487
| Closed | -$1.9M | – | 1746 |
|
|
2019
Q1 | $1.9M | Buy |
+49,487
| New | +$1.89M | 0.05% | 471 |
|
|
2018
Q2 | – | Sell |
-12,655
| Closed | -$346K | – | 1651 |
|
|
2018
Q1 | $346K | Sell |
12,655
-64,127
| -84% | -$1.74M | 0.01% | 1555 |
|
|
2017
Q4 | $1.9M | Buy |
+76,782
| New | +$2.12M | 0.03% | 691 |
|
|
2017
Q3 | – | Sell |
-14,665
| Closed | -$407K | – | 2108 |
|
|
2017
Q2 | $407K | Sell |
14,665
-125,192
| -90% | -$3.32M | ﹤0.01% | 1658 |
|
|
2017
Q1 | $3.48M | Buy |
139,857
+69,400
| +98% | +$1.69M | 0.04% | 472 |
|
|
2016
Q4 | $1.52M | Sell |
70,457
-26,698
| -27% | -$583K | 0.01% | 863 |
|
|
2016
Q3 | $2.31M | Sell |
97,155
-164,236
| -63% | -$3.92M | 0.03% | 473 |
|
|
2016
Q2 | $6.11M | Buy |
261,391
+232,533
| +806% | +$5.03M | 0.07% | 203 |
|
|
2016
Q1 | $543K | Sell |
28,858
-61,124
| -68% | -$1.07M | 0.01% | 1259 |
|
|
2015
Q4 | $1.66M | Buy |
+89,982
| New | +$1.61M | 0.04% | 436 |
|
|
2015
Q3 | – | Sell |
-110,379
| Closed | -$1.95M | – | 1624 |
|
|
2015
Q2 | $1.95M | Sell |
110,379
-82,347
| -43% | -$1.47M | 0.04% | 453 |
|
|
2015
Q1 | $3.42M | Buy |
+192,726
| New | +$3.05M | 0.1% | 176 |
|
|
2014
Q4 | – | Sell |
-14,011
| Closed | -$166K | – | 1161 |
|
|
2014
Q3 | $166K | Buy |
+14,011
| New | +$176K | 0.01% | 864 |
|
|
2014
Q2 | – | Sell |
-10,000
| Closed | -$135K | – | 1097 |
|
|
2014
Q1 | $135K | Sell |
10,000
-2,037
| -17% | -$26.7K | 0.01% | 611 |
|
|
2013
Q4 | $144K | Buy |
+12,037
| New | +$142K | 0.01% | 934 |
|
|
2013
Q3 | – | Sell |
-29,468
| Closed | -$273K | – | 932 |
|
|
2013
Q2 | $273K | Buy |
+29,468
| New | +$250K | 0.02% | 721 |
|
Other funds holding BSX
Paloma Partners's BSX Position: Q4 2024 in Review
Paloma Partners sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 16,273 shares — an estimated $1.36M sold.
Paloma Partners first reported a position in BSX in Q2 2013 and held it in 29 quarters. The position peaked at $6.29M in Q4 2020. 1,521 funds tracked by Wall St. Rank hold BSX as of Q4 2024.
- Paloma Partners reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
- Paloma Partners sold 16,273 Boston Scientific shares in Q4 2024, an estimated $1.36M.
- Paloma Partners first reported a position in Boston Scientific in Q2 2013 and held it in 29 quarters.
- Paloma Partners's Boston Scientific position peaked at $6.29M in Q4 2020.
- 1,521 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.
Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.